These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

446 related items for PubMed ID: 6142713

  • 1. Sulfasalazine inhibition of binding of N-formyl-methionyl-leucyl-phenylalanine (FMLP) to its receptor on human neutrophils.
    Stenson WF, Mehta J, Spilberg I.
    Biochem Pharmacol; 1984 Feb 01; 33(3):407-12. PubMed ID: 6142713
    [Abstract] [Full Text] [Related]

  • 2. Human neutrophil Fc gamma RIIIB and formyl peptide receptors are functionally linked during formyl-methionyl-leucyl-phenylalanine-induced chemotaxis.
    Kew RR, Grimaldi CM, Furie MB, Fleit HB.
    J Immunol; 1992 Aug 01; 149(3):989-97. PubMed ID: 1321856
    [Abstract] [Full Text] [Related]

  • 3. Rebamipide suppresses formyl-methionyl-leucyl-phenylalanine (fMLP)-induced superoxide production by inhibiting fMLP-receptor binding in human neutrophils.
    Nagano C, Azuma A, Ishiyama H, Sekiguchi K, Imagawa K, Kikuchi M.
    J Pharmacol Exp Ther; 2001 Apr 01; 297(1):388-94. PubMed ID: 11259567
    [Abstract] [Full Text] [Related]

  • 4. Preventive effect of rebamipide on gastric mucosal cell damage evoked by activation of formyl-methionyl-leucyl-phenylalanine receptors of rabbit neutrophils.
    Kim CD, Hong KW.
    J Pharmacol Exp Ther; 1997 Apr 01; 281(1):478-83. PubMed ID: 9103534
    [Abstract] [Full Text] [Related]

  • 5. Countergradients of nonchemotactic ligands for N-formylmethionylleucylphenylalanine (FMLP) receptors promote FMLP-induced chemotaxis.
    Gray GD, Ohlmann GM.
    Proc Soc Exp Biol Med; 1986 Feb 01; 181(2):256-62. PubMed ID: 2868456
    [Abstract] [Full Text] [Related]

  • 6. Effects of non-steroidal anti-inflammatory drugs on isolated human polymorphonuclear leukocytes (PMN): chemotaxis, superoxide production, degranulation and N-formyl-L-methionyl-L-leucyl-L-phenylalanine (FMLP) receptor binding.
    Shelly J, Hoff SF.
    Gen Pharmacol; 1989 Feb 01; 20(3):329-34. PubMed ID: 2545509
    [Abstract] [Full Text] [Related]

  • 7. Chemotactic peptide binding by intact neutrophils from human neonates.
    Strauss RG, Snyder EL.
    Pediatr Res; 1984 Jan 01; 18(1):63-6. PubMed ID: 6322097
    [Abstract] [Full Text] [Related]

  • 8. Lipopolysaccharide modulates receptors for leukotriene B4, C5a, and formyl-methionyl-leucyl-phenylalanine on rabbit polymorphonuclear leukocytes.
    Goldman DW, Enkel H, Gifford LA, Chenoweth DE, Rosenbaum JT.
    J Immunol; 1986 Sep 15; 137(6):1971-6. PubMed ID: 3018083
    [Abstract] [Full Text] [Related]

  • 9. Studies on the mechanism of inhibition of chemotactic tripeptide stimulated human neutrophil polymorphonuclear leucocyte superoxide production by chloroquine and hydroxychloroquine.
    Hurst NP, French JK, Gorjatschko L, Betts WH.
    Ann Rheum Dis; 1987 Oct 15; 46(10):750-6. PubMed ID: 2825613
    [Abstract] [Full Text] [Related]

  • 10. Taxol inhibits N-formyl-methionyl-leucyl-phenylalanine (FMLP)-induced human neutrophil polarization and H2O2 production while decreasing [3H]FMLP binding.
    Iannone MA, Wolberg G, Reynolds-Vaughn R, Zimmerman TP.
    Agents Actions; 1987 Aug 15; 21(3-4):278-80. PubMed ID: 2891263
    [Abstract] [Full Text] [Related]

  • 11. Preparation and characterization of a derivative of wheat germ agglutinin which specifically inhibits polymorphonuclear leukocyte chemotaxis to the synthetic chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine.
    Perez HD, Elfman F, Chenoweth D, Hooper C.
    J Immunol; 1986 Mar 01; 136(5):1813-9. PubMed ID: 3753994
    [Abstract] [Full Text] [Related]

  • 12. Deactivation of guinea pig pulmonary alveolar macrophage responses to N-formyl-methionyl-leucyl-phenylalanine: chemotaxis, superoxide generation, and binding.
    Daughaday CC, Mehta J, Spilberg I, Atkinson JP.
    J Immunol; 1985 Mar 01; 134(3):1823-6. PubMed ID: 2981922
    [Abstract] [Full Text] [Related]

  • 13. Enhancement of N-formyl-methionyl-leucyl-phenylalanine (fMLP) binding to isolated human neutrophils.
    Psychoyos S, Smith CW.
    Agents Actions; 1989 Mar 01; 26(3-4):372-7. PubMed ID: 2735228
    [Abstract] [Full Text] [Related]

  • 14. Inhibitory effects of spinorphin, a novel endogenous regulator, on chemotaxis, O2- generation, and exocytosis by N-formylmethionyl-leucyl-phenylalanine (FMLP)-stimulated neutrophils.
    Yamamoto Y, Kanazawa T, Shimamura M, Ueki M, Hazato T.
    Biochem Pharmacol; 1997 Sep 15; 54(6):695-701. PubMed ID: 9310346
    [Abstract] [Full Text] [Related]

  • 15. The protein kinase C inhibitor AEB071 (sotrastaurin) modulates migration and superoxide anion production by human neutrophils in vitro.
    Capsoni F, Ongari AM, Reali E, Bosè F, Altomare GF.
    Int J Immunopathol Pharmacol; 2012 Sep 15; 25(3):617-26. PubMed ID: 23058012
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Priming induces functional coupling of N-formyl-methionyl-leucyl-phenylalanine receptors in equine neutrophils.
    Brazil TJ, Rossi AG, Haslett C, McGorum B, Dixon PM, Chilvers ER.
    J Leukoc Biol; 1998 Mar 15; 63(3):380-8. PubMed ID: 9500527
    [Abstract] [Full Text] [Related]

  • 19. A derivative of wheat germ agglutinin specifically inhibits formyl-peptide-induced polymorphonuclear leukocyte chemotaxis by blocking re-expression (or recycling) of receptors.
    Perez HD, Elfman F, Lobo E, Sklar L, Chenoweth D, Hooper C.
    J Immunol; 1986 Mar 01; 136(5):1803-12. PubMed ID: 3753993
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.